Mycophenolate Mofetil Ameliorates Arteriolopathy and Decreases Transforming Growth Factor-β1 in Chronic Cyclosporine Nephrotoxicity

This publication has 43 references indexed in Scilit:

• Effect of mycophenolate mofetil on nitric oxide production and inducible nitric oxide synthase gene expression during renal ischaemia‐reperfusion injury
  Nephrology Dialysis Transplantation, 2001
• Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
  Kidney International, 2001
• Mycophenolate Mofetil Reduces Renal Injury in the Chronic Nitric Oxide Synthase Inhibition Model
  Hypertension, 2001
• DONOR TREATMENT WITH MYCOPHENOLATE MOFETIL
  Transplantation, 2000
• Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
  Nephrology Dialysis Transplantation, 1999
• Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts
  Transplant Immunology, 1996
• Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts
  Transplant Immunology, 1995
• MYCOPHENOLIC ACID, AN INHIBITOR OF IMP DEHYDROGENASE THAT IS ALSO AN IMMUNOSUPPRESSIVE AGENT, SUPPRESSES THE CYTOKINE-INDUCED NITRIC OXIDE PRODUCTION IN MOUSE AND RAT VASCULAR ENDOTHELIAL CELLS
  Transplantation, 1995
• Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney
  Kidney International, 1995
• Cyclosporine-Associated Chronic Nephropathy
  New England Journal of Medicine, 1984